Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 470
Immune Disorders Drugs 198
Cardiovascular Drugs 156
Biopharmaceuticals 133
Infectious Diseases Drugs 128
Drug Discovery 122
Central Nervous System Drugs 107
Endocrine and Metabolic Disorders Drugs 104
Clinical Trials 101
Musculoskeletal Disorders Drugs 97
Pharmaceuticals 91
Leukemia Drugs 84
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 65
Dermatological Drugs 58
Diabetes Drugs 55
Brain Cancer Drugs 51
Skin Cancer Drugs 50
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Respiratory Drugs 39
Immunosuppressive Drugs 37
Gastrointestinal Drugs 35
Infusions and Injectables 32
Drug Delivery 32
Pharmaceutical Intermediates 31
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 28
Bladder Cancer Drugs 27
Analgesics 27
Drugs by Therapeutic Area 24
HIV/AIDS Drugs 23
Kidney Cancer Drugs 22
Antibiotics 22
Prostate Cancer Drugs 19
Colon Cancer Drugs 19
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Anti-Obesity Drugs 7
Cough and Cold Drugs 6
Company Reports 5
Anxiety Drugs 5
Pharmacoeconomics 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Vitamins and Dietary Supplements 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,434 Results (Page 17 of 122)
- Relevance
  Sort by

Coronary Artery Disease Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
129 Pages
Global

From

€4216EUR$4,750USD£3,676GBP

Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
574 Pages
Global

From

€2219EUR$2,500USD£1,935GBP

Graft Versus Host Disease (GvHD) Treatment Market Forecast - Epidemiology & Pipeline Analysis 2022-2027

 Report
May 2022
190 Pages
Global

From

€3107EUR$3,500USD£2,709GBP

Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
1699 Pages
Global

From

€2219EUR$2,500USD£1,935GBP

Immunosuppressants Market 2024-2028

 Report
July 2024
138 Pages
Global

From

€2219EUR$2,500USD£1,935GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Metastatic Non-Small Cell Lung Cancer - Market Insight, Epidemiology and Market Forecast -2032

 Report
November 2023
630 Pages
Global

From

€8432EUR$9,500USD£7,352GBP

Middle East and Africa Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
90 Pages
Middle East, Africa

From

€4216EUR$4,750USD£3,676GBP

Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (captive, merchant), Synthesis (Synthetic, Biotech), Products (mAb, Hormones, Cytokines), Drug (OTC, Rx), Application (Diabetes, oncology, CVD) - Forecast to 2029

 Report
May 2024
535 Pages
Global

From

€4394EUR$4,950USD£3,831GBP

Vascular Endothelial Growth Factor (Vegf) Inhibitors Market 2024-2028

 Report
May 2024
178 Pages
Global

From

€2219EUR$2,500USD£1,935GBP

Global Peptide Therapeutics Market, Drug Dosage, Price & Clinical Trials Insight 2029

 Report
November 2023
1800 Pages
Global

From

€4527EUR$5,100USD£3,947GBP

Global Dendritic Cell Cancer Vaccine Immunotherapy Market, Dosage, Price & Clinical Trials Insight 2026

 Report
October 2020
222 Pages
Global

From

€2663EUR$3,000USD£2,322GBP

Paracetamol IV - Global Strategic Business Report

 Report
October 2025
374 Pages
Global

From

€5193EUR$5,850USD£4,527GBP

Schizophrenia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
January 2024
185 Pages
Global

€4434EUR$4,995USD£3,866GBP

Medulloblastoma- Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1331EUR$1,500USD£1,161GBP

Bladder Cancer Treatment Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

 Report
October 2023
101 Pages
Global

From

€3500EUR$4,224USD£3,158GBP

Sickle-Cell Anemia Therapeutics - Global Strategic Business Report

 Report
October 2025
181 Pages
Global

From

€5193EUR$5,850USD£4,527GBP

Kidney Cancer Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

 Report
February 2024
93 Pages
Global

From

€3500EUR$4,224USD£3,158GBP

Paracetamol IV Market Size, Share & Trends Analysis Report By Indication (Pain, Pyrexia), By Application (Surgical, Non-surgical), By End Use (Hospitals, Clinics), By Region (North America, Asia Pacific), And Segment Forecasts, 2025 - 2030

 Report
November 2024
150 Pages
Global

From

€5281EUR$5,950USD£4,605GBP

Sickle Cell Disease Treatment - Global Strategic Business Report

 Report
October 2025
182 Pages
Global

From

€5193EUR$5,850USD£4,527GBP

Hematological Malignancies - Global Strategic Business Report

 Report
October 2025
193 Pages
Global

From

€5193EUR$5,850USD£4,527GBP

2,434 Results (Page 17 of 122)
- 1
- 15
- 16
- 17
- 18
- 19

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.